Thoratec Corporation

Wunderlich Securities has initiated coverage on Thoratec Corporation (NASDAQ: THOR) with a Hold rating and $35 price target.

JP Morgan has raised the price target on Thoratec (NASDAQ: THOR) from $28 to $32 and maintains its Neutral rating.

Piper Jaffray is lowering its investment opinion on Thoratec Corporation (NASDAQ: THOR) from Overweight to Neutral. “Based on the company's 2011 revenue outlook, near term growth prospects in the underlying VAD market may be slower than we had expected,” Piper Jaffray writes. “Coupled with a new...

Piper Jaffray has downgraded Thoratec Corporation (NASDAQ: THOR) from Overweight to Neutral and has lowered the price target from $40 to $27.

Today, Auriga USA announced that it has downgraded shares of Thoratec Corporation (NASDAQ: THOR) from Buy to Hold. Auriga USA has also lowered its price target from $85 to $29. Thoratec Corporation currently trades at $31.67.

Thoratec Corporation (NASDAQ: THOR) reported solid 3Q results Thursday after the close, with total revenues of $91.0M (+40%) coming in “$800k above our forecast and $1.5M better than Street consensus,” J.P. Morgan reports. On the bottom line, adjusted EPS of $0.32 (+44%) beat J.P. Morgan's estimate...